The title compound, （4R,5R）-1,3-dioxolance-4,5-bis（2-pyridineacrboxylic acid）, has been synthesized and characterized by single-crystal X-ray diffraction, IR, NMR, and MS analyses. Crystal structure of the title c...The title compound, （4R,5R）-1,3-dioxolance-4,5-bis（2-pyridineacrboxylic acid）, has been synthesized and characterized by single-crystal X-ray diffraction, IR, NMR, and MS analyses. Crystal structure of the title compound was grown from ETOH by slow diffusion at room temperature. The title compound crystallizes in monoclinic, space group C2 with a = 17.805（3）, b = 11.459（3）, c = 11.1656（17） , β = 113.066（4）°, V = 2095.9（6） 3, Z = 4, F（000） = 880, Dc = 1.332 Mg/m-3, C23H20N2O6, Mr = 420.41 and μ = 0.10 mm-1展开更多
基金Supported by the NNSFC (20872051)Foundation of Jiangsu Provincial Key Laboratory of Fine Petrochemical Technology (KF0807)
文摘The title compound, （4R,5R）-1,3-dioxolance-4,5-bis（2-pyridineacrboxylic acid）, has been synthesized and characterized by single-crystal X-ray diffraction, IR, NMR, and MS analyses. Crystal structure of the title compound was grown from ETOH by slow diffusion at room temperature. The title compound crystallizes in monoclinic, space group C2 with a = 17.805（3）, b = 11.459（3）, c = 11.1656（17） , β = 113.066（4）°, V = 2095.9（6） 3, Z = 4, F（000） = 880, Dc = 1.332 Mg/m-3, C23H20N2O6, Mr = 420.41 and μ = 0.10 mm-1
